Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy.

Andrew W StaceyMai TsukikawaIdo Didi FabianSarah TurnerHelen JenkinsonVicky SmithZishan NaeemBruce MorlandJohn R AinsworthM Ashwin ReddyManoj ParulekarMandeep S Sagoo

Published in: The British journal of ophthalmology (2020)

Adjuvant laser in the treatment of retinoblastoma is safe and does not lead to increased rate of vitreous recurrence. Final visual acuity is determined by the presence of tumour at the fovea and not the use of laser.

Keyphrases

optical coherence tomography
early stage
high speed
squamous cell carcinoma
newly diagnosed
replacement therapy